全国新增和(或)修订药学服务收费项目分析与研究  

Analysis and research on new additions and revisions pharmaceutical care charge items in China

作　　者：钟安妮 罗俊[1] 蒋文硕 杨莉[2] 李草 陆浩 赵志刚[2,3] 张宏亮 ZHONG Anni;LUO Jun;JIANG Wenshuo;YANG Li;LI Cao;LU Hao;ZHAO Zhigang;ZHANG Hongliang(Department of Pharmacy,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China;Department of Pharmacy,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China;School of Pharmaceutical Sciences,Capital Medical University,Beijing 100069,China;Yizheng Hospital Management Development(Beijing)Center,Beijing 101399,China)

机构地区：[1]广西医科大学第一附属医院药学部,南宁530021 [2]首都医科大学附属北京天坛医院药学部,北京100070 [3]首都医科大学药学院,北京100069 [4]壹正医院管理发展(北京)中心,北京101399

出　　处：《临床药物治疗杂志》2025年第2期45-52,共8页Clinical Medication Journal

基　　金：北京药学会临床药学研究项目(LCYX-2022-24)。

摘　　要：目的探讨全国新增和(或)修订的药学服务收费项目,为我国药学服务收费工作推进、优化、拓展提供新思路。方法收集2023年9月28日至2024年11月19日全国各省、自治区、直辖市卫生健康委员会、医疗保障局等医政部门官方网站发布的新增和(或)修订的药学服务收费项目相关政策文件,汇总、分析各地区药学服务收费项目、价格、监督指标等。结果全国共18个地区新增和(或)修订了药学服务收费项目,涵盖12项收费项目。其中,药学门诊诊察(查)、住院诊察(查)(临床药学加收)和院内会诊(药师或临床药师)是各类药学服务收费项目占比的前3项,分别为94%、67%和39%。各地区在收费项目设立、收费标准、监测评估等方面均存在差异。结论药学服务收费项目的设置、收费测算方式、支付机制等问题影响我国药学服务收费工作全面推进,同时存在各地区标准不统一、实施路径缺乏等问题,与我国药学服务收费起步晚、体系不成熟、区域间医疗资源分配不均等有关。应加强研究及各地区协同,建立国家层面的政策、标准、实施方案和路径。Objective To investigate the newly added and/or revised pharmaceutical care charge items across China,and to provide new insights for the advancement,optimization,and expansion of pharmaceutical service charging systems within the country.Methods Official policy documents related to the newly added and/or revised pharmaceutical care charge items,issued between September 28,2023,and November 19,2024,were collected from the official websites of provincial-level health commissions,medical insurance bureaus,and other relevant medical administrative departments in various provinces,autonomous regions,and municipalities throughout China.A comprehensive summary and analysis were conducted on the pharmaceutical service charge items,pricing structures,regulatory indicators,and other relevant factors across various regions.Results A total of 18 regions across the nation have implemented additions and/or revisions to pharmaceutical service charge items,covering 12 distinct service categories.Pharmaceutical outpatient consultation,inpatient consultation with a clinical pharmacy surcharge,and inhospital consultation involving pharmacists or clinical pharmacists emerged as the top three categories of these charge items,accounting for 94%,67%and 39%,respectively.Significant variations exist across regions in the establishment of pharmaceutical service charge items,fee standards,and monitoring and evaluation mechanisms.Conclusion The comprehensive development of pharmaceutical service charging in China is hindered by issues such as the categorization of charge items,methodologies for fee calculation,and reimbursement mechanisms.Additionally,inconsistencies in standards and a lack of uniform implementation strategies across regions are prevalent.These challenges are linked to the relatively recent introduction and underdeveloped nature of pharmaceutical service charging systems,as well as the uneven distribution of medical resources across regions.It is essential to strengthen regional collaboration and conduct further research t

关 键 词：药学服务 收费项目 新增 修订 拓展 

分 类 号：R95[医药卫生—药学]